Global Surgical Incision Closure Market Size By Type (Disposable Surgical Incision Closure, Reusable Surgical Incision Closure), By Application (Esophagectomy, Gastrectomy), By Region, And Segment For...

The Global Surgical Incision Closure Market was valued at USD 7.3 billion in 2023 and is projected to reach USD 12.6 billion by 2031, growing at a CAGR of 7.1% during the forecast period from 2023 to 2031. The growth of this market is primarily driven by the increasing number of surgical procedures globally, rising demand for minimally invasive surgeries, and advancements in wound closure technologies. As the burden of chronic diseases grows and healthcare infrastructure improves worldwide, particularly in emerging economies, the demand for effective, rapid, and aesthetic surgical incision closure methods is accelerating.

Drivers:

1. Growth in Surgical Volumes:

Aging populations, increasing lifestyle-related conditions, and improved access to healthcare are driving the global number of surgeries, which in turn fuels demand for advanced surgical closure solutions.

2. Demand for Minimally Invasive Procedures:

Minimally invasive surgeries reduce trauma, recovery time, and infection risk. The need for compatible and aesthetic closure techniques, such as absorbable sutures and tissue adhesives, is rising accordingly.

3. Technological Advancements:

Innovations such as antimicrobial sutures, smart closure devices, and bioactive adhesives are transforming the market, offering faster healing and better clinical outcomes.

Restraints:

1. High Cost of Advanced Closure Products:

Advanced surgical closure materials and devices can be expensive, especially for hospitals in low- and middle-income countries, hindering widespread adoption.

2. Risk of Surgical Site Infections (SSIs):

Despite improvements, SSIs remain a concern and can result from improper wound closure techniques, negatively impacting patient outcomes and hospital performance metrics.

Opportunity:

1. Growth in Ambulatory Surgical Centers and Cosmetic Surgeries:

An increase in outpatient and cosmetic procedures globally creates significant opportunities for high-performance and aesthetically appealing closure products.

2. Expansion in Emerging Markets:

Rapid healthcare development in Asia-Pacific, Latin America, and parts of the Middle East & Africa is expected to generate new demand for surgical incision closure solutions.

Market by System Type Insights:

The sutures segment dominated the market in 2023, holding the largest share due to their widespread use across various types of surgeries. However, the adhesives and sealants segment is projected to grow at the fastest rate, driven by their increasing use in cosmetic, pediatric, and laparoscopic procedures for improved cosmetic outcomes and reduced recovery time.

Market by End-use Insights:

Hospitals accounted for the highest market share in 2023, benefiting from high surgical volumes and institutional adoption of advanced closure technologies. Meanwhile, the ambulatory surgical centers (ASCs) segment is expected to grow rapidly, attributed to cost-effectiveness, rising preference for outpatient surgeries, and quicker patient discharge.

Market by Regional Insights:

North America led the global market in 2023 due to high healthcare spending, a strong focus on surgical innovation, and the presence of leading players. However, Asia-Pacific is projected to experience the fastest growth rate during the forecast period, driven by increasing surgical procedures, healthcare infrastructure development, and rising medical tourism in countries like India, China, and Thailand.

Competitive Scenario:

Key companies in the Global Surgical Incision Closure Market include Johnson & Johnson (Ethicon), Medtronic plc, B. Braun Melsungen AG, Smith & Nephew plc, 3M Company, Baxter International Inc., Teleflex Incorporated, Integra LifeSciences, Stryker Corporation, and Advanced Medical Solutions Group plc. These players are actively investing in product innovation, mergers & acquisitions, and geographical expansion.

In 2023, Ethicon introduced a next-generation antibacterial suture with enhanced coating for SSI prevention.

In 2024, Medtronic launched a minimally invasive closure device tailored for laparoscopic procedures.

Smith & Nephew acquired a surgical adhesive startup in 2025 to expand its advanced wound management portfolio.

Scope of Work – Global Surgical Incision Closure Market

Report Metric Details

Market Size (2023) USD 7.3 billion

Projected Market Size (2031) USD 12.6 billion

CAGR (2023–2031) 7.1%

Market Segments By System Type (Sutures, Staples, Adhesives, Strips), By End-use (Hospitals, ASCs, Clinics), By Region

Growth Drivers Increase in surgeries, rise of minimally invasive procedures, tech advancements

Opportunities Growth in ASCs, demand in emerging markets

Key Market Developments:

2023: Ethicon (Johnson & Johnson) launched a new antibacterial suture line targeting high-risk surgery segments.

2024: Baxter International unveiled a biodegradable skin adhesive for pediatric wound closure.

2025: Smith & Nephew expanded into Asia-Pacific with a new manufacturing facility focused on wound closure systems.

FAQs:

1. What is the current market size of the Global Surgical Incision Closure Market?

The market was valued at USD 7.3 billion in 2023.

2. What is the major growth driver of the Global Surgical Incision Closure Market?

The increasing number of surgeries and demand for minimally invasive procedures are the major growth drivers.

3. Which is the largest region during the forecast period in the Global Surgical Incision Closure Market?

North America is the largest region by market share.

4. Which segment accounted for the largest market share in the Global Surgical Incision Closure Market?

The sutures segment held the largest market share in 2023.

5. Who are the key market players in the Global Surgical Incision Closure Market?

Key players include Johnson & Johnson (Ethicon), Medtronic, B. Braun, Smith & Nephew, 3M, and Baxter.